153P Safety/tolerability and antitumor activity of sitravatinib plus tislelizumab (TIS) in patients with advanced platinum-resistant ovarian cancer (PROC)
Title:
153P Safety/tolerability and antitumor activity of sitravatinib plus tislelizumab (TIS) in patients with advanced platinum-resistant ovarian cancer (PROC)
Author:
Goh, J.C. Coward, J. Gao, B. Pires Da Silva, I. Voskoboynik, M. Day, D. Body, A. Gan, H.K. Li, X. Sun, J. Fei, C. Yang, L. Millward, M.